James Fox

TTP Group Plc engages in the provision of technology and product development services through its subsidiaries. It helps large and small companies to recognize, create and exploit new technologies. The company in October 1987 and is headquartered in Royston, the United Kingdom.

Part of TTP Group Ltd., Technology Partnership Plc is a British company that specializes in developing new products and technologies for clients in various industries such as healthcare, industrials, consumer, and communications. The company is based in Melbourn, UK. The company's website provides examples of their work and information about their services.

Altitude Aerospace Interiors Ltd. manufactures, engineers, and designs cabin interiors. The company is based in Auckland, New Zealand. Altitude Aerospace Interiors was acquired by AIM Aviation Ltd., a subsidiary of the Government of China, from Air New Zealand Ltd. on September 30, 2014.

Planet Innovation Pty Ltd. is a healthtech innovation and Australian commercialization company that specializes in product development and manufacturing. The private company is based in Box Hill, AU. and has subsidiaries in the United States. It was founded in 2009 by Eduardo Vom, Sam Lanyon, Stuart Elliott, and Troy O'Callaghan, with Stuart Elliott serving as the CEO since its inception.

Novasyte LLC provides market, clinical, and field service assistance to the healthcare industry. It offers contract clinical, field technical, SMART recall and inside sale program services. The company was founded by Timothy James Gleeson and Joe Andrew in 2008 and is headquartered in Carlsbad, CA.

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.